Dr. Geraldine Walsh
For the second year, the International Society of Blood Transfusion (ISBT) offered their annual congress online. In June 2021, the virtual “ISBT In Focus” explored the latest in transfusion medicine and science, immunohematology and cellular therapies. In today’s blog, two Canadian Blood Services’ delegates describe their experiences at the congress.
An article recently published on the Canadian Blood Services’ professional education website looks back on the impact of the pandemic on blood donation in Canada.
Through the Centre for Innovation’s competitive funding programs, Canadian Blood Services conducts and supports researchers and research projects in key areas. Recipients for one of our most dynamic programs, the BloodTechNet Award, were recently announced, and several other funding opportunities are now open for applications.
The Canadian Blood Services Lifetime Achievement Award recognizes individuals whose landmark contributions are both extraordinary and world class in the field of transfusion or transplantation medicine, stem cell or cord blood research in Canada and/or abroad.
The Centre for Innovation is delighted to announce the winners of the 2020-2021 Canadian Blood Services Lay Science Writing Competition. Read on to find out who won!
You may be aware that there’s no deferral for blood donors after they receive a vaccine against COVID-19. But you might be wondering how the blood operators made this decision. Canadian Blood Services' medical director for donor and clinical services, Dr. Mindy Goldman, answers questions.
A pandemic, and a possible blood-derived treatment, means blood operators like Canadian Blood Services have found themselves playing a unique role in national and international clinical trials. Canadian Blood Services social scientist, Dr. Kelly Holloway, and her collaborators, were recently awarded funding to understand the role and experience of blood operators as they navigate this new landscape.
The Intramural Research Grant Program, one of the Centre for Innovation’s most responsive and impactful research funding programs, and the Kenneth J. Fyke Program, which supports health services and policy research, are both open for applications.
Blood plasma-derived IVIg holds promise as a treatment for Alzheimer’s disease. A new study suggests that combining IVIg with a new drug delivery technique that helps get IVIg into the brain could increase its effectiveness and help make the best use of this precious treatment.
The Centre for Innovation is the heart of Canadian Blood Services’ research and development activities. Its latest annual report, covering the fiscal year 2019-2020, is now available on blood.ca.